⏱ 14 min read
Hospital 366 Days · Case No. 2
The hospital’s year does not end at 365. It runs to 366, and keeps going.
Call him Jimmy. Age, occupation, location, and any potentially identifying details have been changed. The clinical pattern is a composite reconstructed from late-presentation cases that American emergency rooms see repeatedly over a year, and it does not represent any specific patient.
Hidradenitis suppurativa usually ends quietly on a chart. A dermatologist confirms the pattern of recurrent nodules in the apocrine folds, biologic therapy or surgery is staged, and the disease is brought under management. American clinics see this sequence every week. What they see less often is a severe hidradenitis suppurativa clinical presentation that never enters that sequence at all.
The patient in this case did not enter it. Four years on, the disease has moved from a single armpit nodule to a network of subcutaneous sinus tracts that runs from the left axilla along the lateral chest wall and into the upper flank. The emergency department received him on a Friday morning in late May.
He was 48. The typical hidradenitis suppurativa profile shows symptom onset in the early twenties and an average diagnostic delay close to ten years, with the disease tracking with smoking and with low socioeconomic status. He fit those baselines. His chart held the rest: about 22 pack-years, a chronic alcohol exposure history, no regular medical care, no primary care physician, and an insurance gap that opened six months before this visit when the job ended.
His emergency-department labs showed CRP 24.1, ESR 62, AST 71, ALT 32, hemoglobin 11.4. No fever. Pain reported at 8 out of 10. Skin ultrasound of the left axilla and lateral chest wall confirmed multiple interconnecting subcutaneous sinus tracts extending toward the upper flank, with surrounding soft-tissue edema and no acute abscess collection requiring emergent drainage. Hurley Stage III hidradenitis suppurativa, by clinical exam.
This is not what every American man in his late forties with a recurrent skin lump should expect. Recurrent skin lumps are common. Hurley Stage III hidradenitis suppurativa in a man who has never seen a dermatologist is less common. What separates the two is the patient’s risk profile and what does or does not get added to a chart over four years.
Pea-Sized in the Left Axilla
May 22, 2026. 8:47 a.m. The emergency department registered a 48-year-old man, walk-in, complaint “spreading sore in armpit, four years.” Triage placed him in a treatment room within twenty minutes. He had driven himself in. He took off his work shirt before the nurse asked, and reflexively held his left arm away from his body. He looked tired.
Call him Jimmy. He was a cheerful man, and he had been a hard worker. He had spent the last twenty-two years on construction sites in north Florida. He started at nineteen, swinging a hammer for an old framer who smoked Marlboros at lunch, and Jimmy started smoking too. About 22 pack-years on the chart. Weekends he grilled in the yard with three or four guys from his crew. He had insurance through the job until November of last year.
The first thing the disease showed him was a lump the size of a pea in the left axilla. He figured it was a boil.
That was four years earlier, in the spring of 2022. The lump burst and healed. Two months later it came back. By the end of that year there was not one lump but a row, joined under the skin by something firm that felt like a cord. Yellow stains began to set into the armpits of his shirts. What arrived before the pain was the smell. Indoors, in the truck, at the diner counter, before he had said a word. He started keeping his distance from people. He layered on cologne, kept his arm pinned to his side, and skipped lunch with the crew.
A person’s own nose is the last to know; everyone around him registers it sooner. As he drifted away from people he filled the empty hours with continuous smoking and unmanaged habits. Over time the cuts and scrapes that come with construction work stopped registering as anything worth noting. The antibiotics he had picked up from successive emergency-room visits became a standing pattern, and somewhere along the way they seemed to stop working.
It was not that going to a doctor never crossed his mind. It was that the picture of taking his shirt off in an exam room and showing that part of himself stopped him at the door every time. So one year passed, and then another. By the fourth year the wound had moved out of the armpit and was traveling down the lateral chest wall toward the flank. By then the job was gone. The insurance was gone with it. What was accumulating was the wound, the financial strain, and the physical decline. He had never seen a primary care physician. He had never been referred to a dermatologist.
This past Friday morning he drove himself in.
This is not one real patient. It is a clinical pattern that recurs, in the same shape, across the medical literature and the public data. The description of the man ends here. What this case looks at is not Jimmy. It is the years before the name.
Four Years, Compressed to Eight Dates
Spring 2022 (Year 0). Single pea-sized nodule, left axilla. Self-managed at home as a boil.
Late 2022 (Year 0.5). Recurrence; lesions began joining under the skin; first appearance of malodorous drainage.
Late 2023 (Year 1.5). Yellow staining of work shirts became routine. First day Jimmy started avoiding social meals with the crew.
February 2024 (Year 1.8). First emergency-department visit. Chart diagnosis: “recurrent armpit infection.” Oral antibiotic course. No specialty referral. No follow-up.
July 2024 (Year 2.2). Second emergency-department visit. Same diagnosis. Same prescription. Same discharge.
March 2025 (Year 2.9). Third emergency-department visit. The wound had begun spreading inferior to the axilla. Same management.
November 2025 (Year 3.5). Layoff. Employer health insurance lapsed at the end of December.
May 22, 2026 (Year 4.0). Current emergency-department arrival. Wound extending along the lateral chest wall into the upper flank.
In four years, Jimmy was seen in an emergency department at least three times for the same disease, completed three antibiotic courses, and received zero specialty referrals. None of his three earlier visits crossed the threshold for admission. All three are the exact precursor pattern that American emergency departments see in late-presentation hidradenitis suppurativa every month.
Hidradenitis Suppurativa: What the Emergency Department Found
Triage at 8:47 a.m. Vitals: blood pressure 138/84, heart rate 92, respiratory rate 16, oxygen saturation 98%, temperature 36.9°C. No fever. Pain reported at 8 out of 10.
Lab results: WBC 11.8 (mild leukocytosis). Hemoglobin 11.4 (consistent with anemia of chronic inflammation). Platelets 412 (reactive thrombocytosis). ESR 62 (moderate elevation). CRP 24.1 (significant systemic inflammation). AST 71, ALT 32 (isolated transaminase elevation matching chronic hepatic alcohol exposure). Creatinine normal. Albumin 3.4 (mildly low). Lactate normal.
Imaging: skin ultrasound of the left axilla and the lateral chest wall. Impression: subcutaneous sinus tract formation confirmed, multiple interconnecting hypoechoic tracts extending from the axilla along the lateral chest wall toward the upper flank, surrounding soft-tissue edema, no acute abscess collection requiring emergent drainage. Chest X-ray normal. No osteomyelitis on plain film.
Clinical staging: Hurley Stage III hidradenitis suppurativa, left axilla with extension to the lateral chest wall and the upper flank.
The emergency physician’s note read the chart from the top down. 48-year-old man, four-year history of recurrent left axillary lesions, treated as recurrent infection across three prior emergency-department visits, no specialty referral on record, no primary care physician. Twenty-two pack-years smoking. Chronic alcohol exposure signs. Uninsured since December.
The orders entered into the consult board were these: Dermatology referral, urgent outpatient; Surgery consult for evaluation of staged wide local excision; Short course oral antibiotic to cover any superimposed bacterial colonization; Pain management; Smoking cessation counseling; Social work consult for Medicaid eligibility screening, FQHC linkage, and hospital charity-care pathway; Wound care education and supplies for discharge; Outpatient follow-up appointments scheduled before discharge.
| Hurley Stage / Metric | Clinical Presentation | Pathology & Recurrence Risk |
|---|---|---|
| Stage I | Single or multiple abscesses | Localized nodule formation without sinus tracts or cicatrization (scarring). Frequently misdiagnosed as simple furuncles. |
| Stage II | Recurrent abscesses | Sinus tract formation and distinct hyperkeratotic scarring. Lesions are widely separated but anatomically linked under the skin. |
| Stage III (Jimmy’s Status) | Diffuse / Near-Diffuse Plaques | Multiple interconnected sinus tracts and active abscesses across an entire anatomical zone (axilla extending to the flank). |
| Inflammatory Markers | CRP 24.1 / ESR 62 | Advanced systemic inflammatory footprint. Paired with hemoglobin 11.4, confirming anemia of chronic inflammation. |
Sources: StatPearls: Hidradenitis Suppurativa; The Lancet (2025).
Four years from the first lump to the first specialty referral, compressed.
From the Reviewer · Eleanor Hayes, M.D.
(A) The difference between “the antibiotic worked” and “the disease is over”
After each of his prior emergency-department visits, Jimmy left with the same message in different words. The wound looked better. The pain was easing. The antibiotic was working. Clinically, what that meant was: one acute flare had quieted. The disease itself had not been engaged. Both statements use the same English word “better.” When a patient is discharged without knowing the difference, the next acute flare is already on the chart, just unwritten.
(B) Why hidradenitis suppurativa is not caught by the standard ED workup
Hidradenitis suppurativa is not a bacterial infection that grows on a culture plate. It is a chronic inflammatory disease that begins with the blockage of a hair follicle. Cultures do not catch it. Imaging does not catch it. A biopsy is used mainly to rule out skin cancer (StatPearls, NCBI Bookshelf). Which means the swab and the scan that anchor a standard emergency-room workup do not reach this diagnosis. For a man who only ever sees an emergency room, the name almost never lands on the discharge paperwork.
(C) The average diagnostic delay, and whose clock runs longest
From the first symptom to the first time anyone says the name, the average is close to ten years. Over that span a patient sees more than three different doctors and is misdiagnosed more than three times (The Lancet, 2025; Saunte 2020). The three forces behind that delay are misdiagnosis, slow referral to a specialist, and the patient’s own embarrassment (Dermatology and Therapy, 2024). That last one matters. Jimmy standing at the door for four years was not laziness. It was the documented way this disease works on the people most likely to have it.
(D) When smoking, chronic alcohol exposure, and the absence of routine care stack on the same patient
Smoking is the single strongest known risk factor. A smoker is roughly 3 times as likely to have hidradenitis suppurativa as a non-smoker (International Wound Journal, 2024). The disease also tracks with low socioeconomic status. In the lowest-income neighborhoods the odds of a new diagnosis run more than 3 times those in the highest (JAMA Dermatology, 2025). Chronic alcohol exposure produces measurable signal at the liver, which is why Jimmy’s AST 71 with an AST higher than ALT pattern is on the chart. None of these three on its own would be unusual. Stacked on the same patient over twenty-two years, the sum is not simple addition. The same disease, in the same anatomical site, progresses faster and clears slower.
(E) What a CRP of 24.1 means in a 48-year-old without comorbidities
A CRP of 24.1 with an ESR of 62, mild leukocytosis, and a hemoglobin of 11.4 reads as “moderate elevation” on most emergency-department templates. In a 65-year-old with multiple comorbidities those numbers carry one weight. In a 48-year-old whose baseline sits closer to normal, the same numbers carry a stronger signal that an active process has been running unchecked for a long time. The hemoglobin 11.4 is anemia of chronic inflammation, and it is the lab finding that says “long” rather than “today.”
(F) The shape of the insurance gap
In the United States, health insurance is tied to a job. When the job ended in November, the insurance ended thirty days later. Among uninsured adults, 38.6 percent put off or skip needed care or medication because of cost, compared with 17 percent of adults with private coverage (KFF, 2026). With the same chronic condition, an uninsured person is 3 to 4 times as likely to delay care as an insured one. When uninsured patients are finally admitted, they receive fewer diagnostic and treatment services and have higher mortality (KFF). Jimmy now lives inside that statistic.
(G) Florida’s coverage gap and the childless-adult rule
Florida is one of ten states that did not expand Medicaid. Texas, Florida, and Georgia together hold roughly three-quarters of the entire national coverage gap (healthinsurance.org). In Florida an adult with no dependent children does not qualify for Medicaid no matter how little he earns. Too poor for a marketplace subsidy, and childless, so no Medicaid either (Florida Voices for Health). A single working-age man like Jimmy falls exactly into that space. And against the common belief that the uninsured do not work, 71 percent of working uninsured adults are not offered coverage by an employer or are not eligible for it (KFF, 2026).
(H) The gap between an ED referral and a kept appointment
This Friday morning was the first time Jimmy’s chart carried referrals to dermatology and to surgery. Whether those referrals turn into appointments is not decided in the emergency department. Specialty-referral follow-through among uninsured patients without a primary care physician runs consistently lower than the general population. The chart shows the order entered. What it cannot show in advance is whether the appointment is kept. For Hurley Stage III hidradenitis suppurativa, the distance between the order and the appointment is where the disease either stops progressing or finishes its slow advance toward extensive surgical excision.
(I) What the published literature describes when the same pattern continues
In patients in this profile who do not engage dermatology, do not start disease-modifying therapy, and do not enter surgical care, the trajectory in the published case series moves in one direction. Hidradenitis suppurativa is progressive. If it is not treated early and effectively, it leads to irreversible damage: extensive scarring, contracture, chronic lymphedema, chronic pain, and systemic inflammation (The Lancet, 2025). Wide local excision becomes the treatment in severe cases. Where the disease has spread from the axilla along the lateral chest wall toward the flank, the surgical field can run from below the elbow through the axilla and along the flank down to the waistline. Reconstruction may be needed. The physical mark is one part of what is left; in cases like this one, the psychological injury is the other.
The gravest published complication of long-neglected hidradenitis suppurativa is malignant transformation of the chronically inflamed tissue into squamous cell carcinoma. In retrospective data the incidence is low, roughly 0.2 to 5.2 percent (Annals of Internal Medicine: Clinical Cases, 2025). Once it occurs the picture is severe. In one review of 95 patients the mean age at diagnosis was 52.9, about 78 percent were men, and the common sites were the buttocks (47.5 percent), the perianal region (18.9 percent), and the genitals (13.9 percent) (International Journal of Dermatology, 2021). Another review reported a mean hidradenitis suppurativa history of 25 years before the cancer, that 48 percent of patients died within 2 years of the cancer diagnosis, and that no case of this malignancy had been reported in axillary disease (British Journal of Plastic Surgery, 2003).
That last note matters for this case. The malignant turn comes almost entirely from long-standing disease in the buttocks and the perineum. It does not mean Jimmy’s axilla goes straight there. It means that is the endpoint medicine has seen when the same disease, in another anatomical site, is left longer. The shape of the curve is known.
(J) What changes the curve from here
Part of Jimmy’s risk profile is already accumulated. Twenty-two years of smoking, twenty-two years of chronic alcohol exposure, twenty-two years without routine care. That part cannot be rewound. The other part can be redrawn from this Friday forward. Whether the dermatology referral is kept. Whether the surgery consult is kept. Whether a primary care physician is registered through an FQHC or charity-care pathway. Whether the smoking cessation referral is accepted. Whether the drinking pattern is tracked. None of those five decisions can be answered in an emergency room. The emergency department completed the first cleanup pass on the surface of the wound. The next four years are decided outside it. As a clinician, what I would want a reader to leave with is not the name of the disease. It is that knowing the name and stopping someone before they reach Hurley Stage III are not the same task.
Two Costs, One Decision Window
| Healthcare Path Scenario | Estimated System / Facility Billing | Estimated Out-of-Pocket Cost |
|---|---|---|
| (1) Actual Cost Over 4 Years (Reactive ED Surges) | ~$4,500 (3 legacy visits & short-course Rx) |
$700 – $1,400 (While insured via employer copays) |
| (2) Hypothetical Early Specialist Intervention (Insured Years) | ~$15,000 (Derm consult & Early Biologic Evaluation) |
$7,000 – $9,000 (Capped at Annual Policy Out-of-Pocket Max) |
| (3) Current Uninsured ED Presentation & Basic Handoff | $2,500 – $4,500 | $1,500 – $4,000 (Sliding-scale FQHC / Charity-care pending) |
| (4) Projected 5-Year Progressive Structural Burden (No Change) | $30,000 – $80,000 (Per staged Wide Local Excision surgery) |
Severe (Long-term disability / Unemployment risk) |
Sources: KFF Uninsured Metrics (2026); JAMA Dermatology Coverage Analysis.
The variable that moves is not the dollar amount. It is whether five decisions that had never been on the same chart at the same time stay on this chart from this Friday forward. The same pattern shows up in other case files. The older men living alone case describes what isolation looks like when it finally arrives in the emergency room. The heart failure after stopping blood pressure medication case describes the same self-discontinuation decision at a different stage of life. On how the American body is made, there is more in a piece on the book by ManClub’s medical reviewer, Eleanor Hayes, M.D.
Tools for Reading Lab Numbers
At 48, an ESR 62, CRP 24.1, AST 71, and a hemoglobin 11.4 can be hard to read without an age-matched reference. Twenty-two pack-years and a chronic alcohol exposure pattern also produce measurable signal in the vascular system. Two calculators that can help:
Blood Work Decoder: ESR, CRP, AST, ALT, and hemoglobin mapped against age-matched reference bands.
Heart Age Calculator: converts smoking, drinking, and blood pressure history into a vascular age.
Jimmy was discharged on Friday afternoon. Three printed appointment slips went out in the discharge envelope. One for dermatology the following Tuesday, one for the surgery consult the week after, and one for an FQHC intake on Wednesday.
He drove home with the slips folded into the visor of his truck. The first thing he did when he got inside was move the cigarette pack from the kitchen counter into a drawer.
Whether that small move holds is not something an emergency department can confirm. The next four years are not decided in the room where the wound was cleaned. They are decided in the rooms Jimmy has not yet entered.
The twenty-two years already on the chart cannot be rewound. The next five years can be drawn again. This case does not show what every American man in his late forties with a recurrent skin lump should expect. It shows what one specific risk profile makes more likely. Whether that profile sits close to the reader’s own is something only the reader closing this page can answer.
This article is for general information and does not provide medical advice. The case described is a composite reconstructed from publicly reported clinical patterns and does not represent any specific patient. Recurrent skin lumps, persistent drainage, malodorous discharge, or new constitutional symptoms should prompt evaluation by a clinician. Antibiotic courses should not be stopped or modified without the prescribing clinician’s guidance. Specialty referrals issued from an emergency-department visit are worth keeping. Clinical content reviewed by Eleanor Hayes, M.D.
Take care of yourself. Nobody else will do it for you.
Wilbur P is the editor of Manclub, leading coverage across health and life. His work is research-driven and built on primary sources a reader can verify – written for men in the second half of life who would rather know than believe. Based in Florida, still learning and still in the fight. Corrections, questions, story tips: [email protected].